The AMR Industry Alliance is one of the largest private sector coalitions set up toprovide sustainable solutions to curb antimicrobial resistance, with over 100 biotech, diagnostics, generics and research-based pharmaceutical companies and associations joining forces. One key contribution the Alliance can make is developing novel medicines to address AMR. In particular the Alliance’s small biotechnology companies play a critical role in developing these medicines, but face dauting market challenges to bring these products to patients.

During this panel discussion, the AMR Industry Alliance will convene a dialogue with its biotechnology members to understand the challenges and opportunities faced in forging the partnerships needed to succesfully develop antimicrobial medicines. Two biotech members of the AMR industry Alliance board wiill be joined by Thomas Cenui, the Alliance chair, along with a TBD venture captial.

Session ID: 412181